181 related articles for article (PubMed ID: 18390987)
1. Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma.
Heemstra KA; van der Deure WM; Peeters RP; Hamdy NA; Stokkel MP; Corssmit EP; Romijn JA; Visser TJ; Smit JW
Eur J Endocrinol; 2008 Jul; 159(1):69-76. PubMed ID: 18390987
[TBL] [Abstract][Full Text] [Related]
2. Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study.
van der Deure WM; Uitterlinden AG; Hofman A; Rivadeneira F; Pols HA; Peeters RP; Visser TJ
Clin Endocrinol (Oxf); 2008 Feb; 68(2):175-81. PubMed ID: 17803697
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
[TBL] [Abstract][Full Text] [Related]
4. The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density.
Heemstra KA; Hoftijzer H; van der Deure WM; Peeters RP; Hamdy NA; Pereira A; Corssmit EP; Romijn JA; Visser TJ; Smit JW
J Bone Miner Res; 2010 Jun; 25(6):1385-91. PubMed ID: 20200941
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
6. The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.
Baqi L; Payer J; Killinger Z; Susienkova K; Jackuliak P; Cierny D; Langer P
Endocr Regul; 2010 Jan; 44(1):9-15. PubMed ID: 20151763
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
[TBL] [Abstract][Full Text] [Related]
10. Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal.
Gao YC; Gu Q; Liu QP; Ge WL; Lu HK
Clin Lab; 2010; 56(3-4):87-93. PubMed ID: 20476639
[TBL] [Abstract][Full Text] [Related]
11. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
Zofkova I; Hill M
Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
[TBL] [Abstract][Full Text] [Related]
12. The impact of a TSH receptor gene polymorphism on thyroid-related phenotypes in a healthy Danish twin population.
Hansen PS; van der Deure WM; Peeters RP; Iachine I; Fenger M; Sørensen TI; Kyvik KO; Visser TJ; Hegedüs L
Clin Endocrinol (Oxf); 2007 Jun; 66(6):827-32. PubMed ID: 17408420
[TBL] [Abstract][Full Text] [Related]
13. The Asp727Glu polymorphism in the TSH receptor is associated with insulin resistance in healthy elderly men.
Peeters RP; van der Deure WM; van den Beld AW; van Toor H; Lamberts SW; Janssen JA; Uitterlinden AG; Visser TJ
Clin Endocrinol (Oxf); 2007 Jun; 66(6):808-15. PubMed ID: 17408423
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone status within the physiological range affects bone mass and density in healthy men at the age of peak bone mass.
Roef G; Lapauw B; Goemaere S; Zmierczak H; Fiers T; Kaufman JM; Taes Y
Eur J Endocrinol; 2011 Jun; 164(6):1027-34. PubMed ID: 21393448
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Stimulating Hormone and Bone Mineral Density: Evidence From a Two-Sample Mendelian Randomization Study and a Candidate Gene Association Study.
van Vliet NA; Noordam R; van Klinken JB; Westendorp RG; Bassett JD; Williams GR; van Heemst D
J Bone Miner Res; 2018 Jul; 33(7):1318-1325. PubMed ID: 29544020
[TBL] [Abstract][Full Text] [Related]
16. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
17. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
[TBL] [Abstract][Full Text] [Related]
18. Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women.
van Rijn LE; Pop VJ; Williams GR
Eur J Endocrinol; 2014 Mar; 170(3):461-8. PubMed ID: 24336745
[TBL] [Abstract][Full Text] [Related]
19. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
Marcocci C; Golia F; Vignali E; Pinchera A
J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects.
Peeters RP; van Toor H; Klootwijk W; de Rijke YB; Kuiper GG; Uitterlinden AG; Visser TJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2880-8. PubMed ID: 12788902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
